Internal Reference Number: FOI_7467
Date Request Received: 05/10/2023 00:00:00
Date Request Replied To: 24/10/2023 00:00:00
This response was sent via: By Email
Request Summary: Biologic medicines in gastroenterology
Request Category: Companies
| Question Number 1: How many patients were treated in the last 3 months by the Gastroenterology department (for any medical condition) with the following biologic drugs: • Adalimumab - Humira • Adalimumab Biosimilar • Filgotinib • Golimumab • Infliximab - Remicade • Infliximab Biosimilar • Mirikizumab • Ozanimod • Risankizumab • Tofacitinib • Upadacitinib • Ustekinumab • Vedolizumab | |
| Answer To Question 1: • Adalimumab – Humira 7 • Adalimumab Biosimilar 72 • Filgotinib 15 • Golimumab <5 • Infliximab – Remicade 23 • Infliximab Biosimilar 277 • Mirikizumab 0 • Ozanimod 0 • Risankizumab 0 • Tofacitinib <5 • Upadacitinib 5 • Ustekinumab 73 • Vedolizumab 79 | |
| Question Number 2: If you are able to link patient treatment to a disease, could you please provide the number of patients treated in the last 3 months for Ulcerative Colitis ONLY with the following biologic drugs: • Adalimumab - Humira • Adalimumab Biosimilar • Filgotinib • Golimumab • Infliximab - Remicade • Infliximab Biosimilar • Mirikizumab • Ozanimod • Risankizumab • Tofacitinib • Upadacitinib • Ustekinumab • Vedolizumab | |
| Answer To Question 2: • Adalimumab - Humira 6 • Adalimumab Biosimilar <5 • Filgotinib 6 • Golimumab <5 • Infliximab - Remicade <5 • Infliximab Biosimilar 57 • Mirikizumab 0 • Ozanimod 0 • Risankizumab 0 • Tofacitinib <5 • Upadacitinib <5 • Ustekinumab 8 • Vedolizumab 46 | |
| To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
